Skip to main content

TOP - March 2021 Vol 14, No 2

Acute lymphoblastic leukemia (ALL) is the most common cancer in pediatric patients, with an overall 5-year survival of >90%.1 The length of treatment for these patients is typically 2 to 3 years and involves several phases (induction, consolidation, and maintenance) and multiple forms of chemotherapy. Read More ›

Since 1980, the incidence of liver and intrahepatic bile duct cancer has more than tripled in the United States, whereas the death rates have more than doubled during this time. Read More ›

When it comes to gathering and assessing social determinants of health (SDoH) as part of a medically appropriate history and examination, it is necessary to employ 5 key strategies, said Allysceaeioun D. Britt, PhD, MPH, Interim Vice President, Office of Faculty Affairs and Development, Meharry Medical College, Nashville, TN, in a presentation during the virtual 2020 Healthcare Administration Alliance Conference. Read More ›

Page 2 of 2